Sound Income Strategies LLC lowered its stake in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 59.1% during the second quarter, HoldingsChannel.com reports. The firm owned 2,599…
Read more Sound Income Strategies LLC Has $120,000 Stock Position in Bristol Myers Squibb Company $BMYBristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash. Continue reading this article with a Barron’s subscription. View Options Source link
Read more Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 BillionBristol Myers Squibb Co. Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small…
Read more BMY Stock Price | Bristol Myers Squibb Co. Stock Quote (U.S.: NYSE) | MarketWatchBristol Myers Squibb Co. Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small…
Read more BMY Stock Price | Bristol Myers Squibb Co. Stock Quote (U.S.: NYSE) | MarketWatchBristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a deal valued at up to $5.8 billion. The pharmaceutical giant announced it will pay…
Read more Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion
